A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced the closing ...

Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced the pricing ...

Sharps (NASDAQ: STSS) , an innovative medical device and Pharmaceutical packaging company offering patented, best-in-class syringe products, has announced the closing of its firm commitment ...

Ladies, and gentlemen, thank you for standing by for the Cigna Group fourth-quarter 2024 results review. (Operator Instructions) As a reminder, ladies and gentlemen, this conference, including the Q&A ...

Premature birth and low birth weight disrupt kidney development substantially, which leads to an increased risk of acute kidney injury, chronic kidney disease and hypertension. Broader awareness ...

Steven Valiquette; Analyst; Mizuho Financial Group ...

Q4 2024 Management View CEO Marc Casper highlighted a strong finish to 2024, with revenue growing 5% year-over-year to $11.4 billion and adjusted EPS up 8% to $6.10. He emphasized market share gains ...

Following the earnings announcement, Quest Diagnostics (NYSE:DGX)' stock price rose by 0.48% in pre-market trading. The stock ...

Sam Samad; Chief Financial Officer, Executive Vice President; Quest Diagnostics Inc ...